Hanmi Pharmaceutical
Asia, Seoul-t'ukpyolsi, South Korea, Seoul'%3e%3cg id='b'%3e%3cpath id='a' stroke='%23000' stroke-width='2' d='M-6-25H6m-12 3H6m-12 3H6'/%3e%3cuse xlink:href='%23a' y='44'/%3e%3c/g%3e%3cpath stroke='%23fff' d='M0 17v10'/%3e%3ccircle r='12' fill='%23cd2e3a'/%3e%3cpath fill='%230047a0' d='M0-12A6 6 0 0 0 0 0a6 6 0 0 1 0 12 12 12 0 0 1 0-24z'/%3e%3c/g%3e%3cg transform='rotate(-123.69)'%3e%3cuse xlink:href='%23b'/%3e%3cpath stroke='%23fff' d='M0-23.5v3M0 17v3.5m0 3v3'/%3e%3c/g%3e%3c/svg%3e)
Description
Established in 1973 in Korea, Hanmi Pharmaceuticals now is one of the top 5 pharmaceutical companies in terms of revenue, and the most R&D
Investor Profile
Hanmi Pharmaceutical has backed more than 5 startups, with 3 new investments in the last 12 months alone. The firm has led 2 rounds, about 40% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Post Ipo Debt, Corporate Round rounds (top funding stages).
- Majority of deals are located in United States, Canada.
- Strong thematic focus on Biotechnology, Biopharma, Health Care.
- Led 2 rounds in the past year.
Stage Focus
- Seed (40%)
- Post Ipo Debt (40%)
- Corporate Round (20%)
Country Focus
- United States (60%)
- Canada (40%)
Industry Focus
- Biotechnology
- Biopharma
- Health Care
- Health Diagnostics
- Clinical Trials
- Artificial Intelligence (Ai)
- Enterprise Software
- Machine Learning
- Medical
- Software
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
